Eluforsen Uses, Dosage, Side Effects and more
Eluforsen is under investigation in clinical trial NCT02532764 (Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients).
| Attribute | Details |
|---|---|
| Trade Name | Eluforsen |
| Generic | Eluforsen |
| Eluforsen Other Names | Eluforsen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
